Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GSK loses first US trial on Paxil birth defect claims

This article was originally published in Scrip

Executive Summary

GlaxoSmithKline has been ordered to pay $2.5 million in damages to the family of three-year-old Lyam Kilker after a US jury ruled that the company negligently failed to sufficiently warn doctors and pregnant women that its antidepressant Paxil (paroxetine) could cause birth defects. The case has been watched closely, as it could shape future litigation against the firm for injuries allegedly caused by Paxil.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts